Overview

Intravenous Lidocaine for Cystectomy Procedures

Status:
Unknown status
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
Patients scheduled for a cystectomy at Charleston Area Medical Center (CAMC) will be enrolled into a randomized, double blinded clinical trial to assess if postoperative pain and ileus are reduced by perioperative intravenous lidocaine infusion versus placebo. The hypothesis is that patients receiving the lidocaine infusion will experience better pain control and ileus resolution. It is believed that lidocaine patients will also have less opioid requirement, less mortality, a shorter length of stay, less nausea /vomiting, and fewer adverse events.
Phase:
N/A
Details
Lead Sponsor:
CAMC Health System
Treatments:
Lidocaine